| 1 | Anti-von Willebrand Factor Nanobody, Caplacizumab (D11160) | 1件: Caplacizumab Caplacizumab | 1件: Caplacizumab
Caplacizumab
(D11160) 💬
| 1件: VWF VWF 💬
| 9件: Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Integrin signaling, Neutrophil extracellular trap formation, PI3K-Akt signaling pathway, Platelet activation 💬 | 1件: 64 64 💬
|
| 2 | Anti-von Willebrand Factor Nanobody, INN = Caplacizumab (D11160) | 1件: Caplacizumab Caplacizumab | 1件: Caplacizumab
Caplacizumab
(D11160) 💬
| 1件: VWF VWF 💬
| 9件: Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Integrin signaling, Neutrophil extracellular trap formation, PI3K-Akt signaling pathway, Platelet activation 💬 | 1件: 64 64 💬
|
| 3 | Caplacizumab (D11160) | 1件: Caplacizumab Caplacizumab | 1件: Caplacizumab
Caplacizumab
(D11160) 💬
| 1件: VWF VWF 💬
| 9件: Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Integrin signaling, Neutrophil extracellular trap formation, PI3K-Akt signaling pathway, Platelet activation 💬 | 2件: 63 63, 64 💬
|
| 4 | Caplacizumab (ALX-0081) (D11160) | 1件: Caplacizumab Caplacizumab | 1件: Caplacizumab
Caplacizumab
(D11160) 💬
| 1件: VWF VWF 💬
| 9件: Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Integrin signaling, Neutrophil extracellular trap formation, PI3K-Akt signaling pathway, Platelet activation 💬 | 1件: 64 64 💬
|
| 5 | Caplacizumab (an anti-von Willebrand Factor Nanobody ALX-0081) (D11160) | 1件: Caplacizumab Caplacizumab | 1件: Caplacizumab
Caplacizumab
(D11160) 💬
| 1件: VWF VWF 💬
| 9件: Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Integrin signaling, Neutrophil extracellular trap formation, PI3K-Akt signaling pathway, Platelet activation 💬 | 1件: 64 64 💬
|
| 6 | Caplacizumab (an anti-von Willebrand Factor Nanobody) (D11160) | 1件: Caplacizumab Caplacizumab | 1件: Caplacizumab
Caplacizumab
(D11160) 💬
| 1件: VWF VWF 💬
| 9件: Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Integrin signaling, Neutrophil extracellular trap formation, PI3K-Akt signaling pathway, Platelet activation 💬 | 1件: 64 64 💬
|